ArticleBJS open2022
Reasons for staying in hospital after video-assisted thoracoscopic surgery lobectomy.
Article in BJS open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
32 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Thoracic day surgery versus thoracic inpatient surgery for treatment of patients with lung cancer: a systematic review and meta-analysis.Journal of cardiothoracic surgery · 2023Pooled it
- Postoperative Symptom Burden in Patients Undergoing Lung Cancer Surgery.Journal of pain and symptom management · 2022Pooled it
- Effect of thoracic paravertebral block and erector spinae plane block on postoperative gastrointestinal function and quality of recovery in patients undergoing thoracoscopic lobectomy: a randomized controlled trial.Annals of medicine · 2025Trial
- Dexmedetomidine and Dexamethasone as Adjuvants to the Local Anesthetic Mixture in Rhomboid Intercostal and Sub-Serratus Block for Video-Assisted Thoracoscopic Surgery: A Randomized, Double-Blind, Controlled Trial.Drug design, development and therapy · 2024Trial
- Global trends and research hotspots in enhanced recovery after surgery (ERAS) for lung cancer resection: a bibliometric and visual analysis (2010-2025).Journal of thoracic disease · 2026Article
- Non-Pharmacological Option in Postoperative Pain: Pilot Study of Intraoperative Pulsed Radiofrequency.Interdisciplinary cardiovascular and thoracic surgery · 2026Article
- Article
- Prolonged Hospitalisation After Lung Cancer Surgery: A Qualitative Study of Patient Experiences of the Reasons for Their Extended Stay.Nursing research and practice · 2026Article
- Identifying Key Variances in Clinical Pathways Associated With Prolonged Hospital Stays Using Machine Learning and ePath Real-World Data: Model Development and Validation Study.JMIR medical informatics · 2025Article
- Temporal Trends in Outcomes and Predictors of Length of Stay following Lung Cancer Resection over 10 Years with Enhanced Recovery After Surgery.Interdisciplinary cardiovascular and thoracic surgery · 2025Article
- Knowledge, attitudes and practices regarding perioperative enhanced recovery after surgery in video-assisted thoracoscopic lobectomy among healthcare professionals.Scientific reports · 2025Article
- Development and validation of an interpretable nomogram for predicting the risk of the prolonged postoperative length of stay for tuberculous spondylitis: a novel approach for risk stratification.BMC musculoskeletal disorders · 2025Article
- A critical approach to research on perioperative pain management.British journal of anaesthesia · 2025Article
- Early Hospital Discharge on Day Two Post-Robotic Lobectomy with Telehealth Home Monitoring.Journal of clinical medicine · 2024Article
- Article
- Stage III NSCLC treatment options: too many choices.Breathe (Sheffield, England) · 2024Review
- Postoperative outcomes in patients with diabetes after enhanced recovery thoracoscopic lobectomy.Surgical endoscopy · 2024Article
- In-hospital thromboprophylaxis variation and the risk of venous thromboembolism after lung cancer surgery: a nationwide cohort study.Interdisciplinary cardiovascular and thoracic surgery · 2024Article
- Intersurgeon variations in postoperative length of stay after video-assisted thoracoscopic surgery lobectomy.JTCVS open · 2024Article
- Exploring the need for reconsideration of trial design in perioperative outcomes research: a narrative review.EClinicalMedicine · 2024Review
Corrections and comments
- Commented on by
- Commented on by
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDespite implementation of enhanced recovery after surgery (ERAS) in lung surgery, potential barriers for improvements should be identified. The aim of this single-centre, prospective ERAS cohort study was to explore reasons for delayed patient discharge after video-assisted thoracoscopic surgery (VATS) lobectomy with a median length of hospital stay (LOS) of 2 days.
methodsConsecutive patients referred for VATS lobectomy were consulted twice daily by an investigator for the primary reasons for continued hospitalization. The secondary outcomes were risk factors for delayed recovery using univariate and multivariate regression analyses.
resultsA total of 147 patients were included (69 with LOS more than 2 days and 78 with LOS of 2 days or less) from April 2020 to December 2020. Air leak (27.7 per cent), pneumonia (20.2 per cent), pain (15.3 per cent), urinary/renal factors (11.0 per cent), atrial fibrillation (7.0 per cent), respiratory failure (4.5 per cent), cognitive factors/delirium (4.3 per cent), gastrointestinal factors (3.8 per cent), oxygen dependency (2.7 per cent), social factors (2.0 per cent), and pleural effusion (1.4 per cent) were important factors for discharge more than 2 days after surgery. The 30-day readmission rate after discharge was 21 per cent for LOS of 2 days or less and 22 per cent for LOS more than 2 days (P = 0.856). On a multivariate regression model, age (per 5-year increase, odds ratio (OR) 1.29, 95 per cent c.i. 1.01 to 1.66, P = 0.043) and forced expiratory volume in 1 s (FEV1) per cent (per 5 per cent increase, OR 0.89, 95 per cent c.i. 0.81 to 0.98, P = 0.021) were significantly related to discharge after more than 2 days.
conclusionDespite a short median LOS of 2 days, air leak, pneumonia, and pain remain the most important challenges for further improvement of the ERAS programme. Age and FEV1 per cent were statistically significant risk factors for LOS longer than 2 days.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.